Island Pharmaceuticals Limited (ASX:ILA)
Australia
· Delayed Price · Currency is AUD 0.420
+0.005 (1.20%)
At close: Mar 6, 2026
Island Pharmaceuticals Revenue
Island Pharmaceuticals had revenue of 40.78K AUD in the half year ending December 31, 2025, a decrease of -95.75%. This brings the company's revenue in the last twelve months to 62.85K, down -84.26% year-over-year. In the fiscal year ending June 30, 2025, Island Pharmaceuticals had annual revenue of 118.91K, down -90.57%.
Revenue (ttm)
62.85K
Revenue Growth
-84.26%
P/S Ratio
1,969.77
Revenue / Employee
n/a
Employees
n/a
Market Cap
123.80M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Botanix Pharmaceuticals | 21.92M |
| Recce Pharmaceuticals | 974.56K |
| Paradigm Biopharmaceuticals | 8.45K |
| Actinogen Medical | 7.36M |
| Starpharma Holdings | 14.58M |
| Arovella Therapeutics | 3.21M |
| Cynata Therapeutics | 1.69M |
| Tetratherix | 2.00M |